Source: Annual Congress 2011 - Lung development and neoplasia



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dmytriiev, K. Dmytriieva, O. Katilov, O. Nazarchuk, A. Staradub, O. Mazulov, K. Dmytriiev (Vinnitsa, Ukraine). Endothelin-1 (ET-1) is a useful biomarker for early detection of ventilator-assotiated pneumonia (VAP) in mehanical ventilation children. Eur Respir J 2011; 38: Suppl. 55, 3810

Member's Comments

No comment yet.

Related content which might interest you: The role of serum inflammatory markers in the detection of ventilation associated pneumonia (VAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Could procalcitonin (PCT) be a marker of effectiveness of antibiotic treatment (ABT) in pregnant with not severe community-acquired pneumonia (CAP)? Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Incidence of ventilator associated pneumonia (VAP) and assessment of serial estimation of procalcitonin levels as a prognostic marker in cases of VAP in a tertiary centre in India Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Procalcitonin and C reactive protein as markers of treatment failure in community-acquired pneumonia Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Fiberoptic bronchoscopy (FB) during noninvasive ventilation (NIV) in COPD with hypercapnic encephalopathy (he) and bronchial hypersecretion due to community-acquired pneumonia (CAP): a case-control study Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure Year: 2009 Continuous positive airway pressure (CPAP) treatment and mortality in community-acquired pneumonia (CAP) Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation Year: 2007 Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Serum C-reactive protein (CRP) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Pulmonary apoptosis and related markers in ventilator acquired pneumonia (VAP) Source: Eur Respir J 2003; 22: Suppl. 45, 13s Year: 2003 Fiberoptic bronchoscopy (FB) in patients with acute respiratory failure (ARF) during non-invasive ventilation (NIV) Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation Year: 2007 Efficacy of non-invasive positive pressure ventilation (NIPPV) in cystic fibrosis (CF) patients with acute respiratory failure (ARF) Source: Eur Respir J 2003; 22: Suppl. 45, 501s Year: 2003 The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 Procalcitonin (PCT) and C-reactive protein (CRP) as markers of the differential diagnosis of severe community acquired pneumonia (sCAP) Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP) Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005 Any roles of extra-pulmonary chronic comorbidity (EPC) in acute respiratory failure (ARF) due to COPD exacerbations needing noninvasive positive pressure mechanical ventilation (NIV)? Source: Eur Respir J 2001; 18: Suppl. 33, 404s Year: 2001 C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005 Serum procalcitonine (PCT) as a marker of respiratory infection by pseudomonas aeruginosa (PA) in patients with COPD or bronchiectasis Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Sequential non-invasive ventilation (NIV) following short-term invasive ventilation (IV) in COPD induced hypercapnic respiratory failure—the concept of pulmonary infection control window (PIC window) and it's value for being used as the Source: Eur Respir J 2003; 22: Suppl. 45, 403s Year: 2003